CrossBridge offers the most comprehensive Software as a Service (SaaS) solution available today for improving outcomes and lowering the cost of treating chronic inflammatory diseases.
CrossBridge offers the most comprehensive Software as a Service (SaaS) solution available today for improving outcomes and lowering the cost of treating chronic inflammatory diseases.
CrossBridge bring CPs – acknowledged to improve outcomes and lower treatment cost – to the treatment and management of chronic inflammatory disease. Our world-class Evidence-Based Medical Library (EBML) running on the CrossBridge SaaS platform, and grounded in medical society clinical guidelines, makes this possible. CrossBridge CPs offer providers the same tool to improve performance and achieve quality targets regardless of payer. Physicians may use evidence-based CPs that are compliant with national guidelines. CrossBridge streamlines workflow/admin, patients begin treatment without delay and with less variability of care…the perfect VBP environment.
CrossBridge technology integrates and aggregates patient data into a common platform, providing a longitudinal view of patient care. Our clinical and financial analytics measure compliance with care pathways and support VBC models for chronic conditions. The CrossBridge platform produces actionable data that optimizes treatment plans, identifies gaps in care, integrates with current systems via an API and provides measures of care quality and outcomes.
CrossBridge operationalizes and scales Value-Based Payment Models with incentives for cost savings and outcome improvements. We are leading the way in Value-Based Pharma Reimbursement, where the contracted price of a drug is data-driven, transparent, reproduceable and based on its measurable benefits – and where Outcomes-Based Pharma Reimbursement is based on the drug’s performance with actual patients.